| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/10/2013 | US8529913 Immunogenic compositions for Streptococcus pyogenes |
| 09/10/2013 | US8529912 Group B Streptococcus polypeptides, nucleic acids and therapeutic compositions and vaccines thereof |
| 09/10/2013 | US8529911 Small Streptococcus pyogenes antigens and their use |
| 09/10/2013 | US8529910 Enterococcus antigens |
| 09/10/2013 | US8529905 Soluble inhibitors of vascular endothelial growth factor and use thereof |
| 09/10/2013 | US8529904 Antigenic peptide comprising sequenc simimlarity to wilm's tumor-1 gene a nd gata-1 transcription factor for use as targeting tools in treatment of cell proliferative disorders; tissue targeted therapy |
| 09/10/2013 | US8529898 Activatable binding polypeptides and methods of identification and use thereof |
| 09/10/2013 | US8529882 Peptidomimetic protease inhibitors |
| 09/10/2013 | US8529881 Peptides for active anti-cytokine immunization |
| 09/10/2013 | CA2693296C Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation |
| 09/10/2013 | CA2673477C Multivalent pneumococcal polysaccharide-protein conjugate composition |
| 09/10/2013 | CA2627200C Novel activin receptor and its uses in treating metabolic disorders |
| 09/10/2013 | CA2610919C Hepatitis c virus nucleic acid vaccine |
| 09/10/2013 | CA2593714C Survivin peptide vaccine |
| 09/10/2013 | CA2569368C Photochromic material comprising a proteorhodopsin apoprotein and retinal analog |
| 09/10/2013 | CA2569367C Composition comprising various proteorhodopsins and/or bacteriorhodopsins and use thereof |
| 09/10/2013 | CA2562157C Processes for preparing eptifibatide |
| 09/10/2013 | CA2544483C Soluble tcr fusion molecules and methods of use |
| 09/10/2013 | CA2492498C Flea and tick octopamine receptor nucleic acid molecules, proteins and uses thereof |
| 09/10/2013 | CA2458627C Human cdr-grafted antibody and antibody fragment thereof |
| 09/10/2013 | CA2446848C Derivatives of magainin |
| 09/10/2013 | CA2433394C Compositions and methods for detection of ehrlichia canis and ehrlichia chaffeensis antibodies |
| 09/10/2013 | CA2431964C Conjugates of erythropoietin (pep) with polyethylene glycol (peg) |
| 09/10/2013 | CA2413237C Alteration of cell membrane for new functions |
| 09/10/2013 | CA2392527C Hbv/hcv virus-like particle |
| 09/10/2013 | CA2373753C Preserving a hemoglobin blood substitute with a transparent overwrap |
| 09/10/2013 | CA2281887C Nucleic acid sequences for atp-binding cassette transporter |
| 09/06/2013 | WO2013131099A1 Method of altering the immundominance hierarchy of hiv gag by dna vaccine expressing conserved regions |
| 09/06/2013 | WO2013131091A1 Chimeric fgf21 proteins with enhanced binding affinity for beta-klotho for the treatment of type ii diabetes, obesity and related metabolic disorders |
| 09/06/2013 | WO2013131019A1 Iaspp phosphorylation and metastatic potential |
| 09/06/2013 | WO2013131014A1 Truncated lysosomal acid lipase |
| 09/06/2013 | WO2013130913A1 Interleukin-10 polypeptide conjugates and their uses |
| 09/06/2013 | WO2013130868A1 Methods for modulating fibrinogen expression |
| 09/06/2013 | WO2013130807A1 Targeted histone acetylation |
| 09/06/2013 | WO2013130684A1 Xten-folate conjugate compositions and methods of making same |
| 09/06/2013 | WO2013130676A1 Modified adiponectin polypeptides and their uses |
| 09/06/2013 | WO2013130351A1 Replacement therapy for dental caries |
| 09/06/2013 | WO2013130188A1 Treating human immunodeficiency virus infections |
| 09/06/2013 | WO2013130132A1 Influenza hemagglutinin variants |
| 09/06/2013 | WO2013129432A1 A MUTANT PROTEIN ENCODED BY THE yddG GENE, AND A METHOD FOR PRODUCING AROMATIC L-AMINO ACIDS USING A BACTERIUM OF THE GENUS ESCHERICHIA |
| 09/06/2013 | WO2013128448A1 Isolated polynucleotides and polypeptides and methods of using same for increasing plant yield, biomass, growth rate, vigor, oil content, abiotic stress tolerance of plants and nitrogen use efficiency |
| 09/06/2013 | WO2013128391A1 Synthetic polypeptides and uses thereof |
| 09/06/2013 | WO2013127816A1 On-column enzymatic cleavage |
| 09/06/2013 | WO2013127809A1 Modulation of seed vigor |
| 09/06/2013 | WO2013127779A1 Glp-1 prodrugs |
| 09/06/2013 | WO2013127752A1 Method for reduction of 1->3 reading frame shifts |
| 09/06/2013 | WO2013127700A1 Method for reduction of 1->2 reading frame shifts |
| 09/06/2013 | WO2013078564A3 Targeted lysosomal enzyme compounds |
| 09/06/2013 | WO2013078562A3 Targeted iduronate-2-sulfatase compounds |
| 09/06/2013 | WO2013067029A9 Fibronectin binding domains with reduced immunogenicity |
| 09/06/2013 | CA2850962A1 Influenza hemagglutinin variants |
| 09/05/2013 | US20130232588 Chimeric Retinoid X Receptors and Their Use in a Novel Ecdysone Receptor-Based Inducible Gene Expression System |
| 09/05/2013 | US20130231464 Methods of use of soluble cd24 for therapy of rheumatoid arthritis |
| 09/05/2013 | US20130231461 Method for the isolation of high density lipoprotein |
| 09/05/2013 | US20130231459 Apolipoprotein a-i mimics |
| 09/05/2013 | US20130231458 Polypeptide for preventing and treating cell hyperplasia |
| 09/05/2013 | US20130231293 Compositions and methods for the therapy and diagnosis of inflammatory bowel disease |
| 09/05/2013 | US20130231287 Pegylated albumin polymers and uses thereof |
| 09/05/2013 | US20130231283 Novel neurturin conjugates for pharmaceutical use |
| 09/05/2013 | US20130231280 Novel Peptide Involved in Energy Homeostasis |
| 09/05/2013 | US20130231277 Chimeric fgf21 proteins with enhanced binding affinity for beta-klotho for the treatment of type ii diabetes, obesity, and related metabolic disorders |
| 09/05/2013 | US20130231273 Shortened tetranectin-apolipoprotein a-1 fusion protein, a lipid particle containing it, and uses thereof |
| 09/05/2013 | US20130231023 Formaldehyde-free proteinaceous binder compositions |
| 09/05/2013 | US20130230918 Novel collectin |
| 09/05/2013 | US20130230903 Proteins with repetitive bacterial-ig-like (big) domains present in leptospira species |
| 09/05/2013 | US20130230900 Maize cellulose synthases and uses thereof |
| 09/05/2013 | US20130230892 Variant sucrose transporter polypeptides |
| 09/05/2013 | US20130230885 Lov-domain protein for photosensitive defunctionalization |
| 09/05/2013 | US20130230855 Monocyte-derived Nucleic Acids and Related Compositions and Methods |
| 09/05/2013 | US20130230562 Fusion protein comprising small heat shock protein, cage protein formed thereby, and novel use thereof |
| 09/05/2013 | US20130230548 Truncated l1 protein of human papillomavirus type 52 |
| 09/05/2013 | US20130230546 Chimeric VEGF Peptides |
| 09/05/2013 | US20130230532 Myomegalin variant 8 and uses thereof |
| 09/05/2013 | US20130230529 Novel paramyxovirus and uses thereof |
| 09/05/2013 | US20130230526 Klebsiella antigens |
| 09/05/2013 | US20130230519 Anti-serum albumin binding variants |
| 09/05/2013 | US20130230518 Methods for treating sjogrens syndrome by administering a soluble ctla4 molecule |
| 09/05/2013 | US20130230517 Engineered antibody-interferon mutant fusion molecules |
| 09/05/2013 | US20130230515 Myostatin binding agents |
| 09/05/2013 | US20130230504 Peptide antagonists of vascular endothelial growth factor and methods of use thereof |
| 09/05/2013 | US20130230484 Interleukin-1 Conjugates and Uses Thereof |
| 09/05/2013 | US20130230472 Bonding tissues and cross-linking proteins with naphthalimide compounds |
| 09/04/2013 | EP2634252A2 Method of expressing proteins with disulfide bridges |
| 09/04/2013 | EP2633060A1 Covalent cellulosomes and uses thereof |
| 09/04/2013 | EP2633058A2 Method for mass production of factor vii/viia |
| 09/04/2013 | EP2632952A2 Anti-sod1 antibodies and uses thereof |
| 09/04/2013 | EP2632949A1 Clostridium difficile-specific antibodies and uses thereof |
| 09/04/2013 | EP2632948A1 Spider silk fusion protein structures for binding to an organic target |
| 09/04/2013 | EP2632945A1 Glucose-dependent insulinotropic peptide analogs |
| 09/04/2013 | EP2632944A2 Method for purifying human granulocyte-colony stimulating factor from recombinant e. coli |
| 09/04/2013 | EP2632943A1 Polypeptides having succinyl-coa:aceto acetate transferase activity and polynucleotides encoding same |
| 09/04/2013 | EP2632942A2 Recombinant envelope protein of human immunodeficiency virus (hiv) and vaccine containing the same |
| 09/04/2013 | EP2632941A2 Recombinant hemagglutinin protein of influenza virus and vaccine containing the same |
| 09/04/2013 | EP2632940A1 A method of producing bacteriophage preparations comprising purification using affinity chromatography |
| 09/04/2013 | EP2632936A1 Diketopiperazine forming dipeptidyl linker |
| 09/04/2013 | EP2632562A1 Methods for capturing virus like particles from plants using expanded bed chromatography |
| 09/04/2013 | EP2632494A2 Methods and compositions for assessing and treating cancer |
| 09/04/2013 | EP2632489A2 Compositions targeting the soluble extracellular domain of e-cadherin and related methods for cancer therapy |
| 09/04/2013 | EP2632486A1 Method of rapidly producing vaccines for animals |
| 09/04/2013 | EP2632480A1 Non-natural gelatin-like proteins with enhanced functionality |